Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Shares Down 58.3% – What’s Next?

Posted by ABMN Staff on Nov 27th, 2025

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report)’s share price fell 58.3% during trading on Wednesday . The company traded as low as $3.16 and last traded at $3.5775. 78,120 shares were traded during mid-day trading, an increase of 2,059% from the average session volume of 3,619 shares. The stock had previously closed at $8.58.

Analysts Set New Price Targets

Separately, Pareto Securities downgraded Surgical Science Sweden AB (publ) to a “hold” rating in a research report on Wednesday. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Surgical Science Sweden AB (publ) presently has an average rating of “Hold”.

Read Our Latest Research Report on SUSRF

Surgical Science Sweden AB (publ) Price Performance

The stock’s 50 day moving average price is $8.95 and its 200-day moving average price is $11.94.

About Surgical Science Sweden AB (publ)

(Get Free Report)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.